apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Fulvaa 250 mg Prefilled Syringe Injection 5 ml
  3. Fulvaa 250 mg Prefilled Syringe Injection 5 ml Substitute

Fulvaa 250 mg Prefilled Syringe Injection 5 ml Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

FULVESTRANT-250MG

Uses:

Breast cancer in postmenopausal women

Medicinal Benefits:

Fulvaa 250 mg Prefilled Syringe Injection 5 ml contains Fulvestrant, used to treat breast cancer in postmenopausal women. Additionally, Fulvaa 250 mg Prefilled Syringe Injection 5 ml may be used in combination with palbociclib to treat women with a type of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that is locally advanced or has spread to other parts of the body (metastatic).

FAQs

Fulvaa 250 mg Prefilled Syringe Injection 5 ml contains Fulvestrant which works by inhibiting some of the actions of estrogen (female sex hormone) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.

Fulvaa 250 mg Prefilled Syringe Injection 5 ml is not recommended for patients with severe liver problems. Therefore, if you have any liver problems, inform your doctor before receiving Fulvaa 250 mg Prefilled Syringe Injection 5 ml.

Fulvaa 250 mg Prefilled Syringe Injection 5 ml may cause weakness or tiredness as a common side effect. However, if weakness persists or worsens, please consult your doctor.